3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Urinary Bladder Neoplasms
3
Neoplasms
2
Urothelial Bladder Cancer
1
Urologic Neoplasms
1
Urinary Bladder Diseases
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Driving Under the Influence
1
Disease Progression
1
Carcinoma, Hepatocellular
1
Interventions
pembrolizumab
3
enfortumab vedotin
2
Mitomycin
2
Gemcitabine
2
zidovudine 5'-monophosphate-mannose-albumin conjugate
1
relatlimab
1
galactosamine-conjugated serum albumin-conjugated-(rhodamine X)20
1
Ultrasonography
1
Rivaroxaban
1
Ringer's acetate
1
Radiation Dose Hypofractionation
1
Nivolumab
1
Multiparametric Magnetic Resonance Imaging
1
Fluorouracil
1
Cisplatin
1
CP protocol
1
Albumins
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Urologic Neoplasms
×
Multiparametric Magnetic Resonance Imaging
×
Clear all
NCT04442724
2025-08-14
FMBRT
Cedars-Sinai Medical Center
Phase NA
Recruiting
60 enrolled